Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Arch Biochem Biophys ; 694: 108603, 2020 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-32986977

RESUMO

The alternative oxidase (AOX) catalyzes the transfer of electrons from ubiquinol to oxygen without the translocation of protons across the inner mitochondrial membrane. This enzyme has been proposed to participate in the regulation of cell growth, sporulation, yeast-mycelium transition, resistance to reactive oxygen species, infection, and production of secondary metabolites. Two approaches have been used to evaluate AOX function: incubation of cells for long periods of time with AOX inhibitors or deletion of AOX gene. However, AOX inhibitors might have different targets. To test non-specific effects of n-octyl gallate (nOg) and salicylhydroxamic acid (SHAM) on fungal physiology we measured the growth and respiratory capacity of two fungal strains lacking (Ustilago maydis-Δaox and Saccharomyces cerevisiae) and three species containing the AOX gene (U. maydis WT, Debaryomyces hansenii, and Aspergillus nidulans). For U. maydis, a strong inhibition of growth and respiratory capacity by SHAM was observed, regardless of the presence of AOX. Similarly, A. nidulans mycelial growth was inhibited by low concentrations of nOg independently of AOX expression. In contrast, these inhibitors had no effect or had a minor effect on S. cerevisiae and D. hansenii growth. These results show that nOg and SHAM have AOX independent effects which vary in different microorganisms, indicating that studies based on long-term incubation of cells with these inhibitors should be considered as inconclusive.


Assuntos
Inibidores Enzimáticos/farmacologia , Proteínas Fúngicas/antagonistas & inibidores , Fungos/efeitos dos fármacos , Ácido Gálico/análogos & derivados , Oxirredutases/antagonistas & inibidores , Salicilamidas/farmacologia , Processos de Crescimento Celular/efeitos dos fármacos , Fungos/crescimento & desenvolvimento , Fungos/metabolismo , Ácido Gálico/farmacologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Proteínas Mitocondriais/antagonistas & inibidores , Oxigênio/metabolismo
2.
Arch Biochem Biophys ; 692: 108535, 2020 10 15.
Artigo em Inglês | MEDLINE | ID: mdl-32781052

RESUMO

NAD(P)+ transhydrogenase (NNT) is located in the inner mitochondrial membrane and catalyzes a reversible hydride transfer between NAD(H) and NADP(H) that is coupled to proton translocation between the intermembrane space and mitochondrial matrix. NNT activity has an essential role in maintaining the NADPH supply for antioxidant defense and biosynthetic pathways. In the present report, we evaluated the effects of chemical compounds used as inhibitors of NNT over the last five decades, namely, 4-chloro-7-nitrobenzofurazan (NBD-Cl), N,N'-dicyclohexylcarbodiimide (DCC), palmitoyl-CoA, palmitoyl-l-carnitine, and rhein, on NNT activity and mitochondrial respiratory function. Concentrations of these compounds that partially inhibited the forward and reverse NNT reactions in detergent-solubilized mouse liver mitochondria significantly impaired mitochondrial respiratory function, as estimated by ADP-stimulated and nonphosphorylating respiration. Among the tested compounds, NBD-Cl showed the best relationship between NNT inhibition and low impact on respiratory function. Despite this, NBD-Cl concentrations that partially inhibited NNT activity impaired mitochondrial respiratory function and significantly decreased the viability of cultured Nnt-/- mouse astrocytes. We conclude that even though the tested compounds indeed presented inhibitory effects on NNT activity, at effective concentrations, they cause important undesirable effects on mitochondrial respiratory function and cell viability.


Assuntos
Inibidores Enzimáticos/farmacologia , Mitocôndrias Hepáticas/enzimologia , NADP Trans-Hidrogenase Específica para A ou B/antagonistas & inibidores , NADP Trans-Hidrogenase Específica para A ou B/metabolismo , Consumo de Oxigênio/efeitos dos fármacos , Animais , Inibidores Enzimáticos/química , Feminino , Camundongos , Camundongos Knockout , Mitocôndrias Hepáticas/genética , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , NADP Trans-Hidrogenase Específica para A ou B/genética , Consumo de Oxigênio/genética
3.
Commun Biol ; 3(1): 263, 2020 05 25.
Artigo em Inglês | MEDLINE | ID: mdl-32451394

RESUMO

Moniliophthora perniciosa is a fungal pathogen and causal agent of the witches' broom disease of cocoa, a threat to the chocolate industry and to the economic and social security in cocoa-planting countries. The membrane-bound enzyme alternative oxidase (MpAOX) is crucial for pathogen survival; however a lack of information on the biochemical properties of MpAOX hinders the development of novel fungicides. In this study, we purified and characterised recombinant MpAOX in dose-response assays with activators and inhibitors, followed by a kinetic characterization both in an aqueous environment and in physiologically-relevant proteoliposomes. We present structure-activity relationships of AOX inhibitors such as colletochlorin B and analogues which, aided by an MpAOX structural model, indicates key residues for protein-inhibitor interaction. We also discuss the importance of the correct hydrophobic environment for MpAOX enzymatic activity. We envisage that such results will guide the future development of AOX-targeting antifungal agents against M. perniciosa, an important outcome for the chocolate industry.


Assuntos
Agaricales/efeitos dos fármacos , Agaricales/genética , Fungicidas Industriais/farmacologia , Proteínas Mitocondriais/genética , Oxirredutases/genética , Proteínas de Plantas/genética , Terpenos/farmacologia , Agaricales/química , Agaricales/enzimologia , Relação Dose-Resposta a Droga , Cinética , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/química , Proteínas Mitocondriais/metabolismo , Oxirredutases/antagonistas & inibidores , Oxirredutases/química , Oxirredutases/metabolismo , Proteínas de Plantas/antagonistas & inibidores , Proteínas de Plantas/química , Proteínas de Plantas/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo
4.
Nat Commun ; 10(1): 329, 2019 01 18.
Artigo em Inglês | MEDLINE | ID: mdl-30659190

RESUMO

We previously demonstrated that beta II protein kinase C (ßIIPKC) activity is elevated in failing hearts and contributes to this pathology. Here we report that ßIIPKC accumulates on the mitochondrial outer membrane and phosphorylates mitofusin 1 (Mfn1) at serine 86. Mfn1 phosphorylation results in partial loss of its GTPase activity and in a buildup of fragmented and dysfunctional mitochondria in heart failure. ßIIPKC siRNA or a ßIIPKC inhibitor mitigates mitochondrial fragmentation and cell death. We confirm that Mfn1-ßIIPKC interaction alone is critical in inhibiting mitochondrial function and cardiac myocyte viability using SAMßA, a rationally-designed peptide that selectively antagonizes Mfn1-ßIIPKC association. SAMßA treatment protects cultured neonatal and adult cardiac myocytes, but not Mfn1 knockout cells, from stress-induced death. Importantly, SAMßA treatment re-establishes mitochondrial morphology and function and improves cardiac contractility in rats with heart failure, suggesting that SAMßA may be a potential treatment for patients with heart failure.


Assuntos
Insuficiência Cardíaca/tratamento farmacológico , Proteínas de Membrana/antagonistas & inibidores , Proteínas Mitocondriais/antagonistas & inibidores , Peptídeos/farmacologia , Proteína Quinase C beta/antagonistas & inibidores , Animais , GTP Fosfo-Hidrolases/metabolismo , Técnicas de Inativação de Genes , Insuficiência Cardíaca/metabolismo , Masculino , Membranas Mitocondriais/metabolismo , Contração Miocárdica , Infarto do Miocárdio/metabolismo , Infarto do Miocárdio/patologia , Miócitos Cardíacos/efeitos dos fármacos , Fosforilação , RNA Interferente Pequeno , Ratos Wistar
5.
Plant Physiol Biochem ; 136: 92-97, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30660100

RESUMO

Aluminum (Al) toxicity has been recognized to be a main limiting factor of crop productivity in acid soil. Al interacts with cell walls disrupting the functions of the plasma membrane and is associated with oxidative damage and mitochondrial dysfunction. Jatropha curcas L. (J. curcas) is a drought resistant plant, widely distributed around the world, with great economic and medicinal importance. Here we investigated the effects of Al on J. curcas mitochondrial function and cell viability, analyzing mitochondrial respiration, phenolic compounds, reducing sugars and cell viability in cultured J. curcas cells. The results showed that at 70 µM, Al limited mitochondrial respiration by inhibiting the alternative oxidase (AOX) pathway in the respiratory chain. An increased concentration of reducing sugars and reduced concentration of intracellular phenolic compounds was observed during respiratory inhibition. After inhibition, a time-dependent upregulation of AOX mRNA was observed followed by restoration of respiratory activity and reducing sugar concentrations. Cultured J. curcas cells were very resistant to Al-induced cell death. In addition, at 70 µM, Al also appeared as an inhibitor of cell wall invertase. In conclusion, Al tolerance in cultured J. curcas cells involves a inhibition of mitochondrial AOX pathway, which seems to start an oxidative burst to induce AOX upregulation, which in turn restores consumption of O2 and substrates. These data provide new insight into the signaling cascades that modulate the Al tolerance mechanism.


Assuntos
Alumínio/farmacologia , Jatropha/efeitos dos fármacos , Proteínas Mitocondriais/metabolismo , Oxirredutases/metabolismo , Proteínas de Plantas/metabolismo , Técnicas de Cultura de Células , Jatropha/enzimologia , Jatropha/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Proteínas Mitocondriais/antagonistas & inibidores , Oxirredução/efeitos dos fármacos , Oxirredutases/antagonistas & inibidores , Consumo de Oxigênio/efeitos dos fármacos , Proteínas de Plantas/antagonistas & inibidores
6.
Pest Manag Sci ; 75(5): 1295-1303, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30350447

RESUMO

BACKGROUND: Moniliophthora perniciosa (Stahel) Aime & Phillips-Mora is the causal agent of witches' broom disease (WBD) of cocoa (Theobroma cacao L.) and a threat to the chocolate industry. The membrane-bound enzyme alternative oxidase (AOX) is critical for M. perniciosa virulence and resistance to fungicides, which has also been observed in other phytopathogens. Notably AOX is an escape mechanism from strobilurins and other respiration inhibitors, making AOX a promising target for controlling WBD and other fungal diseases. RESULTS: We present the first study aimed at developing novel fungal AOX inhibitors. N-Phenylbenzamide (NPD) derivatives were screened in the model yeast Pichia pastoris through oxygen consumption and growth measurements. The most promising AOX inhibitor (NPD 7j-41) was further characterized and displayed better activity than the classical AOX inhibitor SHAM in vitro against filamentous fugal phytopathogens, such as M. perniciosa, Sclerotinia sclerotiorum and Venturia pirina. We demonstrate that 7j-41 inhibits M. perniciosa spore germination and prevents WBD symptom appearance in infected plants. Finally, a structural model of P. pastoris AOX was created and used in ligand structure-activity relationships analyses. CONCLUSION: We present novel fungal AOX inhibitors with antifungal activity against relevant phytopathogens. We envisage the development of novel antifungal agents to secure food production. © 2018 Society of Chemical Industry.


Assuntos
Agaricales/efeitos dos fármacos , Agaricales/fisiologia , Benzamidas/síntese química , Benzamidas/farmacologia , Cacau/microbiologia , Proteínas Mitocondriais/antagonistas & inibidores , Oxirredutases/antagonistas & inibidores , Doenças das Plantas/microbiologia , Proteínas de Plantas/antagonistas & inibidores , Antifúngicos/síntese química , Antifúngicos/química , Antifúngicos/farmacologia , Benzamidas/química , Técnicas de Química Sintética , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Relação Estrutura-Atividade
7.
Biochim Biophys Acta ; 1862(10): 1955-63, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27479697

RESUMO

Ceramide accumulation in mitochondria has been associated with reperfusion damage, but the underlying mechanisms are not clearly elucidated. In this work we investigate the role of sphingomyelinases in mitochondrial ceramide accumulation, its effect on reactive oxygen species production, as well as on mitochondrial function by using the sphingomyelinase inhibitor, tricyclodecan-9-yl-xanthogenate (D609). Correlation between neutral sphingomyelinase (nSMase) activity and changes in ceramide content were performed in whole tissue and in isolated mitochondria from reperfused hearts. Overall results demonstrated that D609 treatment attenuates cardiac dysfuncion, mitochondrial injury and oxidative stress. Ceramide was accumulated in mitochondria, but not in the microsomal fraction of the ischemic-reperfused (I/R) group. In close association, the activity of nSMase increased, whereas glutathione (GSH) levels diminished in mitochondria after reperfusion. On the other hand, reduction of ceramide levels in mitochondria from I/R+D609 hearts correlated with diminished nSMase activity, coupling of oxidative phosphorylation and with mitochondrial integrity maintenance. These results suggest that mitochondrial nSMase activity contributes to compartmentation and further accumulation of ceramide in mitochondria, deregulating their function during reperfusion.


Assuntos
Ceramidas/metabolismo , Mitocôndrias Cardíacas/metabolismo , Proteínas Mitocondriais/metabolismo , Traumatismo por Reperfusão Miocárdica/metabolismo , Fosforilação Oxidativa , Esfingomielina Fosfodiesterase/metabolismo , Animais , Hidrocarbonetos Aromáticos com Pontes/farmacologia , Glutationa/metabolismo , Proteínas Mitocondriais/antagonistas & inibidores , Traumatismo por Reperfusão Miocárdica/patologia , Norbornanos , Ratos , Esfingomielina Fosfodiesterase/antagonistas & inibidores , Tiocarbamatos , Tionas/farmacologia
8.
Hum Vaccin Immunother ; 10(5): 1238-43, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24607935

RESUMO

Despite substantial efforts in recent years toward the development of new vaccines and drugs against tuberculosis (TB), success has remained elusive. Immunotherapy of TB with mycobacterial Hsp65 as a DNA vaccine (DNA-hsp65) results in a reduction of systemic bacterial loads and lung tissue damage, but the high homology of Hsp65 with the mammalian protein raises concern that pathological autoimmune responses may also be triggered. We searched for autoimmune responses elicited by DNA-hsp65 immunotherapy in mice chronically infected with TB by evaluating the humoral immune response and comprehensive histopathology using stereology. Cross-reactive antibodies between mycobacterial and mammalian Hsp60/65 were detected; however, no signs of pathological autoimmunity were found up to 60 days after the end of the therapy.


Assuntos
Anticorpos Antibacterianos/imunologia , Autoimunidade/imunologia , Proteínas de Bactérias/imunologia , Chaperonina 60/imunologia , Proteínas Mitocondriais/imunologia , Mycobacterium leprae/imunologia , Vacinas de DNA/imunologia , Animais , Autoimunidade/efeitos dos fármacos , Proteínas de Bactérias/administração & dosagem , Chaperonina 60/administração & dosagem , Chaperonina 60/antagonistas & inibidores , Reações Cruzadas/efeitos dos fármacos , Reações Cruzadas/imunologia , Imunidade Humoral/efeitos dos fármacos , Imunidade Humoral/imunologia , Imunoterapia/métodos , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Mitocondriais/antagonistas & inibidores , Vacinas contra a Tuberculose/administração & dosagem , Vacinas contra a Tuberculose/imunologia , Vacinas de DNA/administração & dosagem
9.
J Bioenerg Biomembr ; 45(3): 243-51, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23609063

RESUMO

Uncoupling proteins (UCP) are able to increase H(+) leakage across the inner mitochondrial membrane, thus dissipating the membrane potential and increasing oxygen consumption. Despite the identification of several UCP orthologs in birds, reptiles, amphibians and fish, little is known about their functional properties in fish. The aim of this work was to identify and characterize a UCP in mitochondria found in goldfish white skeletal muscle. Western blot analysis, using a polyclonal antibody raised against mammalian UCP3, showed a single band at approximately 32 kDa. During non-phosphorylating respiration, we observed that palmitate promoted a dose-dependent increase in oxygen consumption that is abolished by addition of BSA (fatty acid chelator). Interestingly, this palmitate-induced increase in oxygen consumption was not inhibited by GDP, a well-known UCP inhibitor. In phosphorylating mitochondria, palmitate lowered both ADP/O ratio (number of atoms of phosphorus incorporated as ATP per molecule of O2 consumed) and the respiratory control ratio. Moreover, we found that different fatty acids can modulate mitochondrial membrane potential. In conclusion, our results suggest that goldfish UCP is functionally similar to the UCP found in other species, including mammals.


Assuntos
Proteínas de Peixes/metabolismo , Canais Iônicos/metabolismo , Mitocôndrias Musculares/metabolismo , Proteínas Mitocondriais/metabolismo , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Consumo de Oxigênio/fisiologia , Animais , Inibidores Enzimáticos/farmacologia , Proteínas de Peixes/antagonistas & inibidores , Proteínas de Peixes/química , Carpa Dourada , Canais Iônicos/antagonistas & inibidores , Canais Iônicos/química , Mitocôndrias Musculares/química , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/química , Proteínas Musculares/antagonistas & inibidores , Proteínas Musculares/química , Músculo Esquelético/química , Consumo de Oxigênio/efeitos dos fármacos , Ácido Palmítico/farmacologia , Proteína Desacopladora 3
10.
Alcohol Alcohol ; 47(2): 102-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22214999

RESUMO

AIMS: To mimic, in an animal model of alcoholism, the protective phenotype against alcohol consumption observed in humans carrying a fast alcohol dehydrogenase (ADH1B*2) and an inactive aldehyde dehydrogenase (ALDH2*2). METHODS: We developed a multiple expression cassette adenoviral vector (AdV-ADH/asALDH2) encoding both a fast rat ADH and an antisense RNA against rat ALDH2. A control adenoviral vector (AdV-C) containing intronic non-coding DNA was also developed. These adenoviral vectors were administered intravenously to rats bred as high alcohol-drinkers (University of Chile bibulous) that were previously rendered alcohol dependent by a 75-day period of voluntary 10% ethanol intake. RESULTS: Animals administered AdV-ADH/asALDH2 showed a 176% increase in liver ADH activity, whereas liver ALDH2 activity was reduced by 24%, and upon the administration of a dose of ethanol (1 g/kg, i.p.), these showed arterial acetaldehyde levels that were 400% higher than those of animals administered AdV-C. Rats that received the AdV-ADH/asALDH2 vector reduced by 60% their voluntary ethanol intake versus controls. CONCLUSION: This study provides evidence that the simultaneous increase of liver ADH and a reduction of ALDH activity by gene transfer could constitute a potential therapeutic strategy for the treatment of alcoholism.


Assuntos
Álcool Desidrogenase/genética , Consumo de Bebidas Alcoólicas/genética , Alcoolismo/terapia , Aldeído Desidrogenase/antagonistas & inibidores , Técnicas de Transferência de Genes/psicologia , Vetores Genéticos/uso terapêutico , Proteínas Mitocondriais/antagonistas & inibidores , RNA Antissenso/uso terapêutico , Acetaldeído/sangue , Adenoviridae/genética , Álcool Desidrogenase/metabolismo , Consumo de Bebidas Alcoólicas/sangue , Consumo de Bebidas Alcoólicas/metabolismo , Alcoolismo/sangue , Alcoolismo/genética , Alcoolismo/metabolismo , Aldeído Desidrogenase/genética , Aldeído-Desidrogenase Mitocondrial , Animais , Células Cultivadas , Modelos Animais de Doenças , Feminino , Isoenzimas/genética , Isoenzimas/metabolismo , Fígado/metabolismo , Proteínas Mitocondriais/genética , RNA Antissenso/genética , Ratos , Ratos Wistar
11.
PLoS Negl Trop Dis ; 5(10): e1353, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22039556

RESUMO

BACKGROUND: Paracoccidioides brasiliensis is a human thermal dimorphic pathogenic fungus. Survival of P. brasiliensis inside the host depends on the adaptation of this fungal pathogen to different conditions, namely oxidative stress imposed by immune cells. AIMS AND METHODOLOGY: In this study, we evaluated the role of alternative oxidase (AOX), an enzyme involved in the intracellular redox balancing, during host-P. brasiliensis interaction. We generated a mitotically stable P. brasiliensis AOX (PbAOX) antisense RNA (aRNA) strain with a 70% reduction in gene expression. We evaluated the relevance of PbAOX during interaction of conidia and yeast cells with IFN-γ activated alveolar macrophages and in a mouse model of infection. Additionally, we determined the fungal cell's viability and PbAOX in the presence of H2O2. RESULTS: Interaction with IFN-γ activated alveolar macrophages induced higher levels of PbAOX gene expression in PbWt conidia than PbWt yeast cells. PbAOX-aRNA conidia and yeast cells had decreased viability after interaction with macrophages. Moreover, in a mouse model of infection, we showed that absence of wild-type levels of PbAOX in P. brasiliensis results in a reduced fungal burden in lungs at weeks 8 and 24 post-challenge and an increased survival rate. In the presence of H2O2, we observed that PbWt yeast cells increased PbAOX expression and presented a higher viability in comparison with PbAOX-aRNA yeast cells. CONCLUSIONS: These data further support the hypothesis that PbAOX is important in the fungal defense against oxidative stress imposed by immune cells and is relevant in the virulence of P. brasiliensis.


Assuntos
Viabilidade Microbiana , Proteínas Mitocondriais/metabolismo , Oxirredutases/metabolismo , Paracoccidioides/enzimologia , Paracoccidioides/patogenicidade , Proteínas de Plantas/metabolismo , Fatores de Virulência/metabolismo , Animais , Células Cultivadas , Modelos Animais de Doenças , Técnicas de Silenciamento de Genes , Peróxido de Hidrogênio/toxicidade , Pulmão/microbiologia , Macrófagos/imunologia , Macrófagos/microbiologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/genética , Oxidantes/toxicidade , Oxirredutases/antagonistas & inibidores , Oxirredutases/genética , Paracoccidioides/efeitos dos fármacos , Paracoccidioides/imunologia , Paracoccidioidomicose/microbiologia , Paracoccidioidomicose/patologia , Proteínas de Plantas/antagonistas & inibidores , Proteínas de Plantas/genética , RNA Antissenso/genética , RNA Antissenso/metabolismo , Análise de Sobrevida , Virulência , Fatores de Virulência/antagonistas & inibidores , Fatores de Virulência/genética
12.
Eukaryot Cell ; 10(2): 237-48, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21183691

RESUMO

Paracoccidioides brasiliensis is a thermodimorphic human pathogenic fungus that causes paracoccidioidomycosis (PCM), which is the most prevalent systemic mycosis in Latin America. Differentiation from the mycelial to the yeast form (M-to-Y) is an essential step for the establishment of PCM. We evaluated the involvement of mitochondria and intracellular oxidative stress in M-to-Y differentiation. M-to-Y transition was delayed by the inhibition of mitochondrial complexes III and IV or alternative oxidase (AOX) and was blocked by the association of AOX with complex III or IV inhibitors. The expression of P. brasiliensis aox (Pbaox) was developmentally regulated through M-to-Y differentiation, wherein the highest levels were achieved in the first 24 h and during the yeast exponential growth phase; Pbaox was upregulated by oxidative stress. Pbaox was cloned, and its heterologous expression conferred cyanide-resistant respiration in Saccharomyces cerevisiae and Escherichia coli and reduced oxidative stress in S. cerevisiae cells. These results reinforce the role of PbAOX in intracellular redox balancing and demonstrate its involvement, as well as that of other components of the mitochondrial respiratory chain complexes, in the early stages of the M-to-Y differentiation of P. brasiliensis.


Assuntos
Micélio/fisiologia , Oxirredutases/biossíntese , Paracoccidioides/fisiologia , Proteínas Recombinantes de Fusão/biossíntese , Antifúngicos/farmacologia , Antimicina A/farmacologia , Transporte de Elétrons/efeitos dos fármacos , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas Fúngicas/metabolismo , Regulação Fúngica da Expressão Gênica , Humanos , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/genética , Oxirredução , Estresse Oxidativo , Paracoccidioides/citologia , Paracoccidioides/crescimento & desenvolvimento , Proteínas de Plantas , Cianeto de Potássio/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Regulação para Cima
13.
FEBS Lett ; 582(20): 3103-10, 2008 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-18703058

RESUMO

Uncoupling protein 2 (UCP2) is highly expressed in the hypothalamus; however, little is known about the functions it exerts in this part of the brain. Here, we hypothesized that UCP2 protects hypothalamic cells from oxidative and pro-apoptotic damage generated by inflammatory stimuli. Intracerebroventricular injection of tumor necrosis factor alpha (TNF-alpha)-induced an increase of UCP2 expression in the hypothalamus, which was accompanied by increased expression of markers of oxidative stress and pro-apoptotic proteins. The inhibition of UCP2 expression by an antisense oligonucleotide enhanced the damaging effects of TNF-alpha. Conversely, increasing the hypothalamic expression of UCP2 by cold exposure reversed most of the effects of the cytokine. Thus, UCP2 acts as a protective factor against cellular damage induced by an inflammatory stimulus in the hypothalamus.


Assuntos
Apoptose , Hipotálamo/citologia , Hipotálamo/metabolismo , Canais Iônicos/fisiologia , Proteínas Mitocondriais/fisiologia , Animais , Células Cultivadas , Temperatura Baixa , Canais Iônicos/antagonistas & inibidores , Canais Iônicos/biossíntese , Masculino , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/biossíntese , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/farmacologia , Fator de Necrose Tumoral alfa/fisiologia , Proteína Desacopladora 2
14.
J Chemother ; 20(3): 348-54, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18606591

RESUMO

Apoptosis is triggered by two interconnected pathways, extrinsic and intrinsic. The intrinsic pathway is activated by genomic stress promoting mitochondrial release of apoptotic proteins. One of these proteins is Omi/Htra2, a serine protease which inactivates Inhibitor of Apoptosis Proteins (IAPs). In the present work, we assessed the participation of Omi/Htra2 in the cell death induced by the chemotherapeutic drugs 5-fluorouracil (5-FU) and cisplatin (CDDP) in SW480 colon cancer cells. CDDP and 5-FU induced apoptosis mediated by the intrinsic pathway in colon cancer cells, as demonstrated by morphological analyses, mitochondrial cytochrome c release and cleavage of caspase 3. Omi/Htra2 was also released from mitochondria of cells exposed to these drugs, as demonstrated by immunofluorescence and western blot assays of subcellular fractions. Exposure of cells to the Omi/Htra2 serine protease inhibitor UCF-101 prevented death p<0.0001 and partially suppressed reproductive cell death of cells exposed to cisplatin p<0.05, but not to 5-FU p=0.49. From these experiments we show that Omi/Htra2 serine protease activity participates in the cell death induced by CDDP but not of 5-FU in colon cancer cells.


Assuntos
Antineoplásicos/farmacologia , Apoptose , Cisplatino/farmacologia , Neoplasias do Colo/enzimologia , Proteínas Mitocondriais/metabolismo , Serina Endopeptidases/metabolismo , Linhagem Celular Tumoral , Fluoruracila/farmacologia , Serina Peptidase 2 de Requerimento de Alta Temperatura A , Humanos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/enzimologia , Proteínas Mitocondriais/antagonistas & inibidores , Pirimidinonas/farmacologia , Inibidores de Serina Proteinase/farmacologia , Tionas/farmacologia
15.
Toxicol Sci ; 79(1): 189-95, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-14976346

RESUMO

The effects of a chronic aluminum (Al) exposure on biliary secretory function, with special emphasis on hepatic handling of non-bile salt organic anions, was investigated. Male Wistar rats received, intraperitoneally, either 27 mg/kg body weight of Al, as Al hydroxide [Al (+) rats], or the vehicle saline [Al (-) rats] three times a week for 3 months. Serum and hepatic Al levels were increased by the treatment (approximately 9- and 4-fold, respectively). This was associated with enhanced malondialdehyde formation (+110%) and a reduction in GSH content (-17%) and in the activity of the antioxidant enzymes catalase (-84%) and GSH peroxidase (-46%). Bile flow (-23%) and the biliary output of bile salts (-39%), cholesterol (-43%), and proteins (-38%) also decreased. Compartmental analysis of the plasma decay of the model organic anion bromosulphophthalein revealed that sinusoidal uptake and canalicular excretion of the dye were significantly decreased in Al (+) rats (-53 and -43%, respectively). Expression of multidrug resistance-associated protein 2 (Mrp2), the main, multispecific transporter involved in the canalicular excretion of organic anions, was also decreased (-40%), which was associated with a significant decrease in the cumulative biliary excretion of the Mrp2 substrate, dinitrophenyl-S-glutathione (-50%). These results show that chronic Al exposure leads to oxidative stress, cholestasis, and impairment of the hepatic handling of organic anions by decreasing both sinusoidal uptake and canalicular excretion. The alteration of the latter process seems to be causally related to impairment of Mrp2 expression. We have addressed some possible mechanisms involved in these deleterious effects.


Assuntos
Alumínio/intoxicação , Canalículos Biliares/efeitos dos fármacos , Canalículos Biliares/metabolismo , Bile/metabolismo , Glutationa/análogos & derivados , Hidróxido de Alumínio/administração & dosagem , Hidróxido de Alumínio/sangue , Hidróxido de Alumínio/intoxicação , Animais , Bile/efeitos dos fármacos , Ácidos e Sais Biliares/antagonistas & inibidores , Ácidos e Sais Biliares/metabolismo , Catalase/antagonistas & inibidores , Catalase/metabolismo , Colestase/induzido quimicamente , Colesterol/metabolismo , Doença Crônica , Esquema de Medicação , Avaliação Pré-Clínica de Medicamentos/métodos , Expressão Gênica , Glutationa/antagonistas & inibidores , Glutationa/química , Glutationa/efeitos dos fármacos , Glutationa/metabolismo , Glutationa Peroxidase/antagonistas & inibidores , Glutationa Peroxidase/metabolismo , Glutationa Transferase/química , Glutationa Transferase/metabolismo , Injeções Intraperitoneais , Fígado/química , Fígado/efeitos dos fármacos , Masculino , Proteínas Mitocondriais/antagonistas & inibidores , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Proteínas/antagonistas & inibidores , Proteínas/metabolismo , Ratos , Ratos Wistar , Proteínas Ribossômicas/antagonistas & inibidores , Proteínas Ribossômicas/genética , Proteínas Ribossômicas/metabolismo , Proteínas de Saccharomyces cerevisiae/antagonistas & inibidores , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Sulfobromoftaleína/metabolismo , Sulfobromoftaleína/farmacocinética , Substâncias Reativas com Ácido Tiobarbitúrico/química , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA